针对传染病的mRNA疫苗的研究进展
Zhen Zhang1,2, Jingli Du1, Danyang Zhang1
1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, China.
European journal of medical research
|August 23, 2025
概括
传递 RNA (mRNA) 疫苗提供安全有效的预防传染病方法,通过指示身体产生病原体蛋白质. 它们的快速发展和部署,特别是针对COVID-19,凸显了它们未来疫苗创新的潜力.
科学领域:
- 疫苗学
- 分子生物学
- 免疫学
背景情况:
- 传递 RNA (mRNA) 疫苗可以刺激针对病原体的免疫反应.
- 它们在安全性,有效性,生产和成本方面比传统疫苗具有优势.
- 针对COVID-19的mRNA疫苗的成功使人们对这项技术重新产生了兴趣.
研究的目的:
- 审查mRNA疫苗的分子基础,输送系统和免疫机制.
- 总结各种传染病的研究和临床试验进展.
- 讨论mRNA疫苗开发的挑战和未来方向,特别是结核病等细菌感染.
主要方法:
- 对mRNA疫苗技术的文献审查.
- 对多种病原体的研究和临床试验数据的分析.
- 讨论脂质纳米粒子 (LNP) 输送系统.
主要成果:
- mRNA疫苗具有很高的安全性和有效性.
- 脂质纳米粒子 (LNP) 输送对于mRNA疫苗的有效性至关重要.
- 成功的应用包括COVID-19,流感,狂犬病,寨卡病毒,艾滋病毒和结核菌.
结论:
- mRNA疫苗是对抗传染病的强大工具.
- 需要进一步的研究来克服mRNA疫苗应用的挑战.
- 这项技术有望开发针对具有挑战性的病原体的疫苗,
相关概念视频
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Nuclear Export of mRNA
7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Viral Mutations
32.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.9K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Regulated mRNA Transport
6.4K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.4K


